Wataru Shioyama

5PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 27, 2026
Extended Anticoagulation Therapy With Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Different Performance Status Scores: Insights From the ONCO PE Randomized Trial.

Wei Xiong, Yugo Yamashita, Takeshi Morimoto

|Nov 18, 2024
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).

Yugo Yamashita, Takeshi Morimoto, Nao Muraoka

|Oct 22, 2024
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2.

Nobutaka Ikeda, Yugo Yamashita, Takeshi Morimoto

|Sep 30, 2024
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral Anticoagulants.

Ryusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto

|Jul 31, 2024
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era.

Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto

Pageof 1

Frequent Collaborators

5 joint publications

Yugo Yamashita

5 joint publications

Ryuki Chatani

5 joint publications

Yuji Nishimoto

4 joint publications

Kazuhisa Kaneda